STIGALL L. JEREMY (GM, Biologics & Drug Delivery) exercised options at CLEARPOINT NEURO, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/16/2026ACC: 0001193125-26-108077
Officer· GM, Biologics & Drug Delivery
Since May 2022
-15.15K
Net shares
Net seller
$174.7K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
31K acquired · 46.15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+31K
Price / share
—
Trade value
—
% of position
33.5%
3/12/2026
92.64K→123.63K
Common Stock
Direct
Shares
−15.15K
Price / share
$11.53
Trade value
$174.69K
% of position
12.3%
3/12/2026
123.63K→108.48K
Total
Net shares
+15.84K
Net value
-$174.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2026 | M · Option Exercise | +31K | — | — | 33.5% | 92.64K | 123.63K |
| Common Stock Direct | 3/12/2026 | F · Tax Withholding | −15.15K | $11.53 | $174.69K | 12.3% | 123.63K | 108.48K |
| Total | +15.84K | -$174.69K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
31K shares
Shares
−31K
Strike price
Held after
31K
Exercisable
—
3/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock31K shares | 3/12/2026 | M · Option Exercise | −31K | — | 31K |